Joel Greenblatt’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$382K Buy
+34,791
New +$412K ﹤0.01% 1654

Other funds holding ZVRA

Joel Greenblatt's ZVRA Position: Q3 2026 in Review

Joel Greenblatt opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 34,791 shares worth $382K. The stake represents ﹤0.01% of the portfolio and ranks #1654 among its holdings.

176 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Joel Greenblatt held 34,791 shares of Zevra Therapeutics worth $382K as of Q3 2026.
  • Zevra Therapeutics was a new Joel Greenblatt position in Q3 2026.
  • Zevra Therapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1654 holding.
  • 176 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.